These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 2509529

  • 1. Congestive heart failure induced by six of the newer antiarrhythmic drugs.
    Ravid S, Podrid PJ, Lampert S, Lown B.
    J Am Coll Cardiol; 1989 Nov 01; 14(5):1326-30. PubMed ID: 2509529
    [Abstract] [Full Text] [Related]

  • 2. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ.
    Chest; 1985 Oct 01; 88(4):618-24. PubMed ID: 3930162
    [No Abstract] [Full Text] [Related]

  • 3. New drugs in the management of ventricular arrhythmias.
    Sanna GP.
    G Ital Cardiol; 1984 Oct 01; 14(10):788-97. PubMed ID: 6083894
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.
    Gottlieb SS, Kukin ML, Medina N, Yushak M, Packer M.
    Circulation; 1990 Mar 01; 81(3):860-4. PubMed ID: 2106401
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A.
    Am J Cardiol; 1983 Sep 22; 52(6):24C-31C. PubMed ID: 6414279
    [Abstract] [Full Text] [Related]

  • 11. Adverse hemodynamic effects of antiarrhythmic drugs in congestive heart failure.
    Hammermeister KE.
    Circulation; 1990 Mar 22; 81(3):1151-3. PubMed ID: 2106400
    [No Abstract] [Full Text] [Related]

  • 12. Haemodynamic effects of encainide, flecainide, lorcainide and tocainide.
    Vanhaleweyk G, Serruys PW, Hugenholtz PG.
    Eur Heart J; 1984 Sep 22; 5 Suppl B():67-74. PubMed ID: 6437819
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical pharmacology of antiarrhythmic agents.
    Kelliher GJ, Kowey P, Engel T, Wetstein L.
    Cardiovasc Clin; 1985 Sep 22; 16(1):287-305. PubMed ID: 2874883
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The clinical pharmacology of lidocaine congeners--review of encainide, flecainide, lorcainide and tocainide.
    McDevitt DG.
    Eur Heart J; 1984 Sep 22; 5 Suppl B():63-6. PubMed ID: 6437818
    [Abstract] [Full Text] [Related]

  • 19. Therapy with investigational antiarrhythmic drugs.
    Mead RH, Harrison DC.
    Med Clin North Am; 1984 Sep 22; 68(5):1321-37. PubMed ID: 6436596
    [Abstract] [Full Text] [Related]

  • 20. Worsening of arrhythmias during pharmacological treatment.
    Furlanello F, Gramegna L, Dal Forno P, Vergara G, Bettini R, Inama G, Disertori M.
    G Ital Cardiol; 1984 Oct 22; 14(10):798-803. PubMed ID: 6440827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.